Vivanza Biosciences P/E Ratio

Current P/E Ratio
142.0
High Valuation
Very High - High growth expectations or significantly overvalued

Vivanza Biosciences P/E ratio. Vivanza Biosciences (VIVANZA) P/E ratio is 142.0 (High), EPS (TTM) ₹0.10, current price ₹1.44 on BSE — Very High - High growth expectations or significantly overvalued. Also explore VIVANZA share price charts to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 142.0
Current Price ₹1.44
EPS (TTM) ₹0.10
Exchange BSE

Valuation Signal

Signal Overvalued

Sector Context

Sector Average 51.84
Sector Median 29.4
Sector Rank #11 of 255
Sector Percentile 4.3%

Earnings Breakdown (TTM)

TTM EPS ₹0.10
Sept 2026 ₹0.03
Mar 2026 ₹-0.11

VIVANZA P/E Ratio — Valuation Signal & Historical Context

Vivanza Biosciences P/E 142.0 — signal: Overvalued. Check VIVANZA market capitalization to track the company's total market size over time.

  • Stock appears overvalued with PE of 142.0, suggesting caution for new investments
  • Trading at premium to sector average PE of 51.84

VIVANZA vs Healthcare Peers — P/E Ratio Comparison

Vivanza Biosciences P/E 142.0 vs Healthcare average 51.84, median 29.4 — range 2.0–733.0.

Sector Average
51.84
Sector Median
29.4
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low